Delivery Order SPE2DB24D2101-SPE2DB25FKMGX
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,700.12 on July 28, 2025, for the supply of Mounjaro 12.5 mg/0.5 ml pen injections. This firm fixed price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 29, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,918.35 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pens on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order was executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $1,722.19 to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 mL pen injections on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's larger...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency valued at $1,360.45 for the supply of Mounjaro 15 mg/0.5 ml pens, with an ultimate completion date of July 21, 2025. The award was issued on July 18, 2025, under a firm fixed-price contract type with no set-aside designation, indicating competitive procurement. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a $1,360.45 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,586.22 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL). This firm fixed-price delivery order is non-competitive and utilizes a competitively awarded indefinite delivery contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. As a major...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pens in 0.5 mL units. This firm fixed-price delivery order, valued at $1,088.36, is scheduled for completion by September 2, 2025, and represents a non-competitive set-aside award. The order will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a $10,538.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pens on July 2, 2025, with completion scheduled for July 3, 2025. This non-set-aside award represents a routine pharmaceutical procurement to support federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.81 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens (0.5 mL). This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a pediatric or small-quantity pharmaceutical procurement supporting federal medical supply needs. The contract was awarded on a competitive basis with no set-aside designation, utilizing AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen (0.5ml), a diabetes medication. This firm fixed price, competitively awarded delivery order was executed on August 6, 2025, with an ultimate completion date of August 7, 2025. The contract performs at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award derives from AmerisourceBergen's substantial...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKMGXDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,632.54 for Mounjaro 12.5 mg/0.5 ml pen units on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order for pharmaceutical supplies to support federal medical procurement needs. The award was issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company holds an extensive portfolio of federal contract awards with DLA and its Medical Supply Chain, covering diverse therapeutic domains including diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. As the prime contractor on this delivery order, AmerisourceBergen continues to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its flexible pharmaceutical supply vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/14/25 |